Shannon Ferrante
Impact in
- Hepatology top 5%
- Hepatitis C virus research
- Hepatitis Viruses Studies and Epidemiology
- Infectious Diseases top 10%
- Viral gastroenteritis research and epidemiology
- HIV/AIDS drug development and treatment
Papers in
- Hepatology 17
- Hepatitis C virus research 16
-
- HIV/AIDS drug development and treatment 6
- Co-authors
- Max Ciarlet (2 shared papers)Timo Vesikari (2 shared papers)Aino Karvonen (2 shared papers)Elamin H. Elbasha (10 shared papers)Jagpreet Chhatwal (10 shared papers)Antoine C. El Khoury (3 shared papers)Barbara J. Kuter (1 shared paper)Margaret Burroughs (2 shared papers)
- Journals
- Value in Health (8 papers)Advances in Therapy (2 papers)Journal of Hepatology (2 papers)Blood (2 papers)Journal of Clinical Oncology (1 paper)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Shannon Ferrante
35 papers receiving 460 citations
Peers
Comparison fields: 5 of 42
- Hepatology 212
- Infectious Diseases 169
- Virology 16
- Hematology 36
- Cardiology and Cardiovascular Medicine 55
Countries citing papers authored by Shannon Ferrante
This map shows the geographic impact of Shannon Ferrante's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shannon Ferrante with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shannon Ferrante more than expected).
Fields of papers citing papers by Shannon Ferrante
This network shows the impact of papers produced by Shannon Ferrante. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shannon Ferrante. The network helps show where Shannon Ferrante may publish in the future.
Co-authors
The 25 scholars most cited alongside Shannon Ferrante, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 69 | |
| 2 | 2010 | 65 | |
| 3 | 2013 | 57 | |
| 4 | 2013 | 42 | |
| 5 | 2021 | 33 | |
| 6 | 2013 | 28 | |
| 7 | 2022 | 21 | |
| 8 | 2019 | 20 | |
| 9 | 2012 | 18 | |
| 10 | 2019 | 16 | |
| 11 | 2012 | 15 | |
| 12 | 2014 | 12 | |
| 13 | 2021 | 8 | |
| 14 | 2015 | 8 | |
| 15 | 2022 | 7 | |
| 16 | 2022 | 6 | |
| 17 | 2011 | 5 | |
| 18 | 2023 | 4 | |
| 19 | 2013 | 4 | |
| 20 | 2018 | 4 |
About Shannon Ferrante
Shannon Ferrante is a scholar working on Hepatology, Infectious Diseases, Epidemiology, Hematology and Molecular Biology, having authored 36 papers that have together received 469 indexed citations. Recurring topics across this work include Hepatitis C virus research (16 papers), Multiple Myeloma Research and Treatments (7 papers), HIV/AIDS drug development and treatment (6 papers), Hepatitis B Virus Studies (5 papers), Liver Disease Diagnosis and Treatment (5 papers), Protein Degradation and Inhibitors (4 papers), Chronic Myeloid Leukemia Treatments (2 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Hepatology (212 citations), Infectious Diseases (169 citations), Virology (16 citations), Hematology (36 citations) and Cardiology and Cardiovascular Medicine (55 citations). Shannon Ferrante has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Max Ciarlet, Timo Vesikari, Aino Karvonen, Elamin H. Elbasha, Jagpreet Chhatwal, Antoine C. El Khoury, Barbara J. Kuter, Margaret Burroughs, Daniel Parks and Yogesh Punekar. Their work appears in journals such as Value in Health, Advances in Therapy, Journal of Hepatology, Blood and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.